France : Drug Eluting Stents (DES) market
Updated: Jul 17, 2020
DES market revenues have been flatenning over the past 3 years. In 2019, DES national tariffs (LPPR) decreased of -17.1% (€760 to €630) even though it doesn't reflect real-life tariffs, especially in public hospitals where prices are much lower. Consequently we observe a drop of -3.4% in total revenues (2018 vs 2019 : €201M.).
To get the full report, please contact-us : firstname.lastname@example.org